Oyster Point Pharmaceuticals

Developer of gene therapies to treat ophthalmological diseases

placePrinceton, New Jersey, United States calendar_todayFounded 2015 groups303 employees language oysterpointrx.com

Registered entities

Investor mix

6 investors on record; lead investors include New Enterprise Associates, Versant Ventures, Invus, Flying L Partners; 2 have since exited.

Investor typeCountShare
Venture capital583%
Private equity117%
Coming soon